DrugPatentWatch Database Preview
Litigation Details for Abbott Laboratories v. Impax Laboratories Inc. (D. Del. 2007)
Abbott Laboratories v. Impax Laboratories Inc. (D. Del. 2007)
| Docket | Start Trial | Date Filed | 2007-06-18 |
| Court | District Court, D. Delaware | Date Terminated | 2008-05-14 |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 4,913,906; 4,988,731; 5,212,326; 5,286,497; 6,419,953; 6,511,678; 6,528,090; 6,528,091; 6,713,086; 6,720,004 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Abbott Laboratories v. Impax Laboratories Inc.
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , and Start Trial .
Details for Abbott Laboratories v. Impax Laboratories Inc. (D. Del. 2007)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2007-06-18 | 1 | Complaint | Clted U.S. PATENT DOCUMENTS 4,369,172 A 1/1983 Schor et al. 4,699,927 A 10/1987 Deboeck 4,913,906 A 4/1990… lower incidence of side effects for patients 4,913,906 A 4/1990 Friedman et ol. consuming such a formulation…formulation including sodium valproate. U.S. Pat, No. 4,913,906 to Frledrnan, et al. discloses a controlled release…formulation including sodium valproate. U.S. Pat. No. 4,913,906 to Friedman, et al discloses a controlled release… infringe the ‘086 patent and the °090 patent, but did not argue that either patent is invalid or unenforceable | External link to document |
| 2007-07-27 | 14 | Answer to Complaint | formulation including sodium valproate. U.S. Pat. No. 4,913,906 to Friedman, et al. discloses a controlled release…4,699,927 A 10/1987 Deboeck ()F ])[VALPR()EX S()])IUM 4,913,906 A 4/1990 Friedman er al. 4,988,731 A 1/1991 Meade…formulation including sodium valproate. U.S. Pat. No. 4,913,906 to Friedman, et al. discloses a controlled release…steady-state levels have been achieved This results in a 4,913,906 A 4/1990 Friedman et al. significantly lower incidence…formulation including sodium valproate. U.S. Pat. No. 4,913,906 to Friedman, et al discloses a controlled release | External link to document |
| 2007-07-30 | 15 | Proposed Order | Certiiication, i.e., U.S. Patent-Nos.~654-l*9,»9§3___~»»~~- (“the ‘953 patent”); 6,511,678 (“the ‘687 pateiit…Abbott owns certain patents, including U.S. Patent Nos. 6,'713,086 (“the ‘086 patent”) and 6,528,090 …original patents at issue, the ‘090 and ‘086 patents, as well as four additional related patents, the ‘953…090 patents Thus, linpax seeks approval to market its product prior to the expiry of these patents As…086 and ‘090 patent and added Declaratory Judgment Counterclaims against those two patents relating to | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
